BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 1848916)

  • 1. Treatment of severe Plasmodium falciparum malaria with quinidine gluconate: discontinuation of parenteral quinine from CDC drug service.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Apr; 40(14):240. PubMed ID: 1848916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with quinidine gluconate of persons with severe Plasmodium falciparum infection: discontinuation of parenteral quinine from CDC Drug Service.
    MMWR Recomm Rep; 1991 Apr; 40(RR-4):21-3. PubMed ID: 1850497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion.
    Miller KD; Greenberg AE; Campbell CC
    N Engl J Med; 1989 Jul; 321(2):65-70. PubMed ID: 2659994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chloroquine-resistant falciparum malaria with a combination of quinine, quinidine and cinchonine (LA40221) in adults by oral and intravenous administration.
    Bunnag D; Harinasuta T; Vanijanonta S; Looareesuwan S; Chittamas S; Punnavut W; Berth J; Druilhe P
    Acta Leiden; 1987; 55():139-49. PubMed ID: 3321829
    [No Abstract]   [Full Text] [Related]  

  • 5. Availability and use of parenteral quinidine gluconate for severe or complicated malaria.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Dec; 49(50):1138-40. PubMed ID: 11190119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous quinidine gluconate in the treatment of severe Plasmodium falciparum infections.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(24):371. PubMed ID: 3923321
    [No Abstract]   [Full Text] [Related]  

  • 7. Ineffectiveness of continuous quinidine gluconate infusion in the treatment of severe chloroquine-resistant Plasmodium falciparum malaria.
    Matsuura GK; Chan LA
    Drug Intell Clin Pharm; 1988 Nov; 22(11):883-5. PubMed ID: 3069426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compared response to chloroquine, fansidar, quinine, and quinidine slow release of infections with Plasmodium falciparum in the Kivu region of Zaire.
    Delacollette C; Cibanguka J; Buregea H; Nkera J
    Acta Leiden; 1987; 55():159-62. PubMed ID: 3321832
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies.
    Phillips RE; Warrell DA; White NJ; Looareesuwan S; Karbwang J
    N Engl J Med; 1985 May; 312(20):1273-8. PubMed ID: 3887162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The anti-arrhythmia drug quinidine as an alternative in the treatment of severe falciparum malaria].
    Ris HB; Stahel E; Pittet JF; Friedemann M
    Schweiz Med Wochenschr; 1983 Feb; 113(7):254-8. PubMed ID: 6340187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous-infusion quinidine gluconate for treating children with severe Plasmodium falciparum malaria.
    Rudnitsky G; Miller KD; Padua T; Stull TL
    J Infect Dis; 1987 May; 155(5):1040-3. PubMed ID: 3549916
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous artesunate for the treatment of severe malaria.
    Hess KM; Goad JA; Arguin PM
    Ann Pharmacother; 2010; 44(7-8):1250-8. PubMed ID: 20551300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro response of Plasmodium falciparum to amodiaquine, quinine and quinidine in Tanga region, Tanzania.
    Kilimali VA
    East Afr Med J; 1990 May; 67(5):336-40. PubMed ID: 2202587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous quinidine gluconate and exchange transfusion for malignant Plasmodium falciparum malaria.
    Green G
    Del Med J; 1994 Oct; 66(10):553. PubMed ID: 7958120
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo and in vitro responses to quinine and quinidine of Plasmodium falciparum.
    Sabchareon A; Chongsuphajaisiddhi T; Sinhasivanon V; Chanthavanich P; Attanath P
    Bull World Health Organ; 1988; 66(3):347-52. PubMed ID: 3048758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium falciparum malaria and intravenous quinidine gluconate.
    Agosti JM; Miller KD; Pappaioanou M; Jong EC
    Ann Intern Med; 1985 Aug; 103(2):307. PubMed ID: 3893261
    [No Abstract]   [Full Text] [Related]  

  • 17. Availability of parenteral quinidine gluconate for treatment of severe or complicated malaria.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jun; 45(23):494-5. PubMed ID: 8628210
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutics review: the use of parenteral drugs for falciparum malaria.
    Davidson RN; Stein CM; Houston S
    Cent Afr J Med; 1990 Oct; 36(10):259-63. PubMed ID: 2092877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous artesunate for severe malaria.
    Prescrire Int; 2008 Aug; 17(96):168-70. PubMed ID: 19492495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of blood schizontocidal activity of quinine and quinidine against drug resistant rodent malaria.
    Kazim M; Puri SK; Dutta GP
    J Commun Dis; 1991 Dec; 23(4):254-6. PubMed ID: 1842807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.